cSSSI: Complicated skin and skin-structure infection; ESBL: Extended spectrum β lactamase; MRSA: Methicillin-resistant ... have been recently developed. Novel antibiotics, such as linezolid ...

In addition, the relatively short follow-up makes it impossible to determine if treatment had an impact on recurrence, treatment failure or re-infection, especially in chronic skin conditions.

When that happens, your infection will be said to be antibiotic resistant, and your physician will have to prescribe a different drug to combat it. MRSA: The Spread of Drug Resistance In fact ...

US scientists have discovered a new family of antibiotics in soil samples ... on rats that they had given MRSA and it eliminated the infection in skin wounds. The researchers are now working ...

Medically reviewed by Susan Bard, MD Having psoriasis, an autoimmune condition that causes inflamed skin patches, can make you more likely to develop certain skin infections. A combination of ...

Basilea will seek approval of ceftobiprole for SAB as well as acute bacterial skin and skin structure infection (ABSSSI ... % of the total market for anti-MRSA antibiotics, so FDA approval ...

Testing market is projected to expand steadily over the next decade, rising from an estimated USD 4.3 billion in 2025 to USD ...

In this context, studies of PTK0796 — the first in a new aminomethylcycline class of antibiotics ... skin structure infections (cSSSI), in which approximately 50% of the infecting bacteria were ...